Between Tesla, SpaceX (Starship & Starlink), 5G, mRNA vaccines and more, 2020 has been an eventful year full of breakthroughs all set to make our lives better, and ushering in a sci-fi future quicker than ever…so I brought them all together in one video to celebrate the great people working tirelessly to make our future better.
If you want a feel good boost, why not drop by and spend a few mins revelling in the positive stories of 2020.
Have an awesome New Year!!
In Looking Back At 2020 I want to review the year to show that for all the bad, there was still some amazing good and positive stories that refused to take a back seat.
Colorado public health officials on Tuesday confirmed the first U.S. case of the new highly contagious strain of the coronavirus that was first discovered in Britain weeks ago, prompting a new set of lockdowns there.
A state lab informed the Centers for Disease Control and Prevention (CDC) about the presence of the strain in a man in his 20s from Elbert County. He has no travel history and is isolating himself until cleared by public health officials, Gov. Jared Polis said in a statement.
An experimental drug reversed age-related declines in memory and mental flexibility in old mice after just a few doses, according to a study by researchers from the University of California, San Francisco (UCSF).
The drug, ISRIB, has previously been shown in other studies to restore normal cognitive function in mice after traumatic brain injury, enhance memory in healthy mice and mice with Down syndrome, as well as prevent noise-related hearing loss.
Is the author of the book Free To Choose Medicine: Better Drugs Sooner at Lower Cost; a book that offers a compelling argument for the freedom of every patient, guided by the advice of his or her doctor, to make informed decisions about the use of not-yet-FDA-approved therapeutic drugs, that are in late stages of clinical testing.
Mr. Madden is recently retired as a Managing Director of Credit Suisse/Holt after a career in money management and investment research that included the founding of Callard Madden & Associates. During his career, he developed the cash-flow return on investment (CFROI) valuation framework that is widely used today by money management firms worldwide.
Mr. Madden is currently an independent researcher and a Senior Fellow at the National Center for Policy Analysis (NCPA). His research has focused on the themes of knowledge building and wealth creation being able to exist simultaneously in businesses, and these themes are represented in his various books including — Value Creation Principles: The Pragmatic Theory of the Firm Begins with Purpose and Ends with Sustainable Capitalism, Wealth Creation: A Systems Mindset for Building and Investing in Businesses for the Long Term, and Reconstructing Your Worldview: The Four Core Beliefs You Need to Solve Complex Business Problems.
Mr. Madden is a proponent of the application of systems thinking to public policy, and his work in public policy has resulted in the Free To Choose Medicine (http://freetochoosemedicine.com/) plan, which was originally developed in journal articles published in Regulation, Cancer Biotherapy & Radiopharmaceuticals, and Medical Hypotheses.
Mr. Madden is passionate about the passage of a Free To Choose Medicine Act which would be a defining moment for Americans giving control of medical decisions back to individual patients and their doctors.
Robots from Japan: the new Toyota robot, giant robot, robot waiter and other technology news 2020. High Technology News 2020. Science and Technology News 2020. The newest and coolest robots from Japan and around the world.
In this issue: 0:00 Introduction. 0:29 Home robots from Toyota Research Institute. 1:29 Toyota robotic grip. 2:06 barista robot from OrionStar. 3:17 Japanese robot avatar Model-T 4:16 giant robot Gundam. 4:58 robot waiter Servi. 5:28 OSIRIS-REx space robot. 6:08 system to create realistic humanoid robots Mesmer. 6:50 new 3D printing method for artificial muscles and wearable devices. 7:35 walking robot excavator Menzi Muck M545 8:05 full warehouse automation. 8:50 MK-IV Hexapod research robot. 9:13 palm payment system Amazon One. 9:50 flying suit for paramedics. 10:31 a robot that will make you an omelette.
Nearly two years ago, Chmielewski underwent a 10-hour brain surgery at the Johns Hopkins Hospital in Baltimore as part of a clinical trial originally spearheaded by the Defense Advanced Research Projects Agency and leveraging advanced prosthetic limbs developed by the Johns Hopkins Applied Physics Laboratory. Its goal was to allow participants to control [assistive devices](https://medicalxpress.com/tags/assistive+devices/), and enable perception of physical stimuli (touching the limbs) using neurosignals from the brain. Surgeons implanted six electrode arrays into both sides of his brain, and within months he was able to demonstrate, for the first time, simultaneous control of two of the [prosthetic limbs](https://medicalxpress.com/tags/prosthetic+limbs/) through a brain-machine interface developed by APL.
For more than 30 years—following an accident in his teens—Robert “Buz” Chmielewski has been a quadriplegic with minimal movement and feeling in his hands and fingers. But last month he was able to manipulate two prosthetic arms with his brain and feed himself dessert.
Buz’s accomplishment marks a big step toward restoring function and autonomy for patients affected by an illness or injury that results in the partial or total loss of use of all four limbs and torso.
“It’s pretty cool,” said Chmielewski, whose sense of accomplishment was unmistakable after using his thoughts to command the robotic limbs to cut and feed him a piece of golden sponge cake. “I wanted to be able to do more of it,” he said.
University of rochester — working at the intersection of aging, DNA repair, and cancer.
Dr. Vera Gorbunova is the Doris Johns Cherry Professor, in the Department of Biology, and Co-director, Rochester Aging Research Center, at University of Rochester.
Her research is focused on understanding the mechanisms of longevity and genome stability and on the studies of exceptionally long-lived mammals.
Dr. Gorbunova earned her B.Sc. degrees at Saint Petersburg State University, Russia, and her Ph.D. at the Weizmann Institute of Science, Israel.
Dr. Gorbunova was instrumental in pioneering the comparative biology approach to studying aging and identifying rules that control the evolution of tumor suppressor mechanisms depending on the species lifespan and body mass.
Global carbon dioxide (CO2) emissions from fossil fuel and industry are expected to drop by 7% in 2020, new analysis shows, as economies around the world feel the effects of Covid-19 lockdowns.
The latest estimates from the Global Carbon Project (GCP) suggest that these emissions will clock in at 34bn tonnes of CO2 (GtCO2) this year – a fall of 2.4GtCO2 compared to 2019.
This annual decline is the largest absolute drop in emissions ever recorded, the researchers say, and the largest relative fall since the second world war.
A former independent presidential hopeful is vexed at the COVID-19 vaccine at the moment, and for multiple reasons. That would be Zoltan Istvan, a self-described transhumanist candidate who was billed as the “cyborg who is running against President Trump” in press reports throughout 2020. The California hopeful — who ran in the Republican primary — based his campaign on a futuristic message of fusing radical technology with daily life under the motto “Upgrade America.”
Mr. Istvan recently looked into how long it would be before he got a COVID-19 vaccine.
“I took the New York Times’ ‘Find your Place’ in the vaccine line report, and I was near the bottom 15% of the timeline for getting the vaccine — meaning I’ll be nearly last,” Mr. Istvan wrote in an email to Inside the Beltway.
Hello rejuvenation friends! Did you know that Heales, the Belgian entity led by Didier Coeurnelle, is financing two very interesting experiments with the great rejuvenation scientists Harold Katcher and Rodolfo Goya in order to test if Elixir (in the case of Katcher) and plasma of young rats (in the case of Goya) are capable to considerably extend the lifespan of rats? Today I found out on Google that six days ago, Didier published this article in Heales website: https://heales.org/wp-content/plugins/multisite-language-switcher/flags/. In the article, Didier explains in depth both experiments, and put the links to the detailed protocol of the experiments, in two Word files. It’s incredible the power of the collaboration of people who are enthusiastic of rejuvenation science, such as Didier, Harold and Rodolfo. I don’t know if the experiment will extend considerably the rats lives, but it seems that these two experiments deserve a close look from the rejuvenation field.
Today, in spite of the gigantic progress in medicine and research, we still do not know how to be healthy beyond about 85 years of age.
